对于病情最严重的肺移植候选者来说,过度选择性接受允诺与较高的候选死亡率有关。

IF 2.6 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Seminars in Thoracic and Cardiovascular Surgery Pub Date : 2024-12-01 DOI:10.1053/j.semtcvs.2022.11.001
Jason W. Greenberg MD, David L.S. Morales MD, Hosam F. Ahmed MD, Mallika V. Desai, Kyle W. Riggs MD, Don Hayes Jr MD, MS, MEd, David G. Lehenbauer MD, Md. M. Hossain PhD, MSc, Farhan Zafar MD, MS
{"title":"对于病情最严重的肺移植候选者来说,过度选择性接受允诺与较高的候选死亡率有关。","authors":"Jason W. Greenberg MD,&nbsp;David L.S. Morales MD,&nbsp;Hosam F. Ahmed MD,&nbsp;Mallika V. Desai,&nbsp;Kyle W. Riggs MD,&nbsp;Don Hayes Jr MD, MS, MEd,&nbsp;David G. Lehenbauer MD,&nbsp;Md. M. Hossain PhD, MSc,&nbsp;Farhan Zafar MD, MS","doi":"10.1053/j.semtcvs.2022.11.001","DOIUrl":null,"url":null,"abstract":"<div><div><span>The demand for organs for lung transplantation (LTx) continues to outweigh supply. However, nearly 75% of donor lungs are never transplanted. LTx offer acceptance practices and the effects on waitlist/post-transplant outcomes by candidate clinical acuity are understudied. UNOS was used to identify all LTx candidates, donors, and offers from 2005 to 2019. Candidates were grouped by Lung Allocation Score (LAS; applicable post-2005, ages ≥12 years): LAS&lt;40, 40–60, 61–80, and &gt;80. Offer acceptance patterns, waitlist death/decompensation, and post-transplant survival (PTS) were compared. “Acceptable organ offers” were those from donors whose organs were accepted for transplantation. Approximately 3 million offers to 34,531 candidates were reviewed. Median waitlist durations were: 9 days-(LAS&gt;80), 17 days-(LAS 61–80), 42 days-(LAS 40–60), 125 days-(LAS&lt;40) (</span><em>P</em> &lt; 0.001 between all). Per waitlist-day, offer rates were: <em>total offers</em> – 0.8/day-(LAS&gt;80), 0.7/day-(LAS 61–80), 0.6/day-(LAS 40–60), 0.4/day-(LAS&lt;40); <em>acceptable offers</em> – 0.34/day-(LAS&gt;80), 0.32/day-(LAS 61–80), 0.24/day-(LAS 40–60), 0.15/day-(LAS&lt;40) (both <em>P</em> &lt; 0.001 between all LAS). Among patients who experienced waitlist mortality/decompensation, ≥1 acceptable offer was declined in 92% (3939/4270) of patients – 78% for LAS &gt;80, 88% for LAS 61–80, 93% for LAS 40–60, and 96% for LAS &lt;40. Thirty-day waitlist mortality/decompensation rates were: 46%-(LAS&gt;80), 24%-(LAS 61–80), 5%-(LAS 40–60), &lt;1%-(LAS&lt;40) (<em>P</em> &lt; 0.001 between all). PTS was equivalent between patients for whom the first/second offer vs later offers were accepted (all LAS <em>P</em> &gt; 0.4). The first offers that LTx candidates receive (including acceptable organs) are declined for nearly all candidates. Healthier candidates can afford offer selectivity but more ill patients (LAS&gt;60) cannot, experiencing exceedingly high 30-day waitlist mortality.</div></div>","PeriodicalId":48592,"journal":{"name":"Seminars in Thoracic and Cardiovascular Surgery","volume":"36 4","pages":"Pages 435-444"},"PeriodicalIF":2.6000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Overly Selective Offer Acceptance is Associated With High Waitlist Mortality for the Most Ill Lung Transplant Candidates\",\"authors\":\"Jason W. Greenberg MD,&nbsp;David L.S. Morales MD,&nbsp;Hosam F. Ahmed MD,&nbsp;Mallika V. Desai,&nbsp;Kyle W. Riggs MD,&nbsp;Don Hayes Jr MD, MS, MEd,&nbsp;David G. Lehenbauer MD,&nbsp;Md. M. Hossain PhD, MSc,&nbsp;Farhan Zafar MD, MS\",\"doi\":\"10.1053/j.semtcvs.2022.11.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div><span>The demand for organs for lung transplantation (LTx) continues to outweigh supply. However, nearly 75% of donor lungs are never transplanted. LTx offer acceptance practices and the effects on waitlist/post-transplant outcomes by candidate clinical acuity are understudied. UNOS was used to identify all LTx candidates, donors, and offers from 2005 to 2019. Candidates were grouped by Lung Allocation Score (LAS; applicable post-2005, ages ≥12 years): LAS&lt;40, 40–60, 61–80, and &gt;80. Offer acceptance patterns, waitlist death/decompensation, and post-transplant survival (PTS) were compared. “Acceptable organ offers” were those from donors whose organs were accepted for transplantation. Approximately 3 million offers to 34,531 candidates were reviewed. Median waitlist durations were: 9 days-(LAS&gt;80), 17 days-(LAS 61–80), 42 days-(LAS 40–60), 125 days-(LAS&lt;40) (</span><em>P</em> &lt; 0.001 between all). Per waitlist-day, offer rates were: <em>total offers</em> – 0.8/day-(LAS&gt;80), 0.7/day-(LAS 61–80), 0.6/day-(LAS 40–60), 0.4/day-(LAS&lt;40); <em>acceptable offers</em> – 0.34/day-(LAS&gt;80), 0.32/day-(LAS 61–80), 0.24/day-(LAS 40–60), 0.15/day-(LAS&lt;40) (both <em>P</em> &lt; 0.001 between all LAS). Among patients who experienced waitlist mortality/decompensation, ≥1 acceptable offer was declined in 92% (3939/4270) of patients – 78% for LAS &gt;80, 88% for LAS 61–80, 93% for LAS 40–60, and 96% for LAS &lt;40. Thirty-day waitlist mortality/decompensation rates were: 46%-(LAS&gt;80), 24%-(LAS 61–80), 5%-(LAS 40–60), &lt;1%-(LAS&lt;40) (<em>P</em> &lt; 0.001 between all). PTS was equivalent between patients for whom the first/second offer vs later offers were accepted (all LAS <em>P</em> &gt; 0.4). The first offers that LTx candidates receive (including acceptable organs) are declined for nearly all candidates. Healthier candidates can afford offer selectivity but more ill patients (LAS&gt;60) cannot, experiencing exceedingly high 30-day waitlist mortality.</div></div>\",\"PeriodicalId\":48592,\"journal\":{\"name\":\"Seminars in Thoracic and Cardiovascular Surgery\",\"volume\":\"36 4\",\"pages\":\"Pages 435-444\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Seminars in Thoracic and Cardiovascular Surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1043067922002611\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in Thoracic and Cardiovascular Surgery","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1043067922002611","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

肺移植(LTx)对器官的需求仍然供不应求。然而,近 75% 的捐献肺从未移植。人们对肺移植的接受方式以及候选者临床敏锐度对等待名单/移植后结果的影响研究不足。UNOS 用于识别 2005 年至 2019 年的所有 LTx 候选人、捐献者和提议。候选者按肺分配评分(LAS;适用于2005年后,年龄≥12岁)分组:LAS80。比较了供体接受模式、等待者死亡/代偿以及移植后存活率(PTS)。"可接受器官供体 "是指器官被接受移植的捐献者。审查了向 34,531 名候选人提供的约 300 万个器官。等待时间的中位数为9天-(LAS>80)、17天-(LAS 61-80)、42天-(LAS 40-60)、125天-(LAS80)、0.7/天-(LAS 61-80)、0.6/天-(LAS 40-60)、0.4/天-(LAS80)、0.32/天-(LAS 61-80),0.24/天-(LAS 40-60),0.15/天-(LAS 80,LAS 61-80 为 88%,LAS 40-60 为 93%,LAS 80 为 96%),24%-(LAS 61-80),5%-(LAS 40-60),0.4)。几乎所有候选人都拒绝了 LTx 候选人收到的第一份录取通知(包括可接受的器官)。较健康的候选者可以承受选择性报价,但病情较重的患者(LAS>60)则无法承受,他们的 30 天等待死亡率极高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Overly Selective Offer Acceptance is Associated With High Waitlist Mortality for the Most Ill Lung Transplant Candidates
The demand for organs for lung transplantation (LTx) continues to outweigh supply. However, nearly 75% of donor lungs are never transplanted. LTx offer acceptance practices and the effects on waitlist/post-transplant outcomes by candidate clinical acuity are understudied. UNOS was used to identify all LTx candidates, donors, and offers from 2005 to 2019. Candidates were grouped by Lung Allocation Score (LAS; applicable post-2005, ages ≥12 years): LAS<40, 40–60, 61–80, and >80. Offer acceptance patterns, waitlist death/decompensation, and post-transplant survival (PTS) were compared. “Acceptable organ offers” were those from donors whose organs were accepted for transplantation. Approximately 3 million offers to 34,531 candidates were reviewed. Median waitlist durations were: 9 days-(LAS>80), 17 days-(LAS 61–80), 42 days-(LAS 40–60), 125 days-(LAS<40) (P < 0.001 between all). Per waitlist-day, offer rates were: total offers – 0.8/day-(LAS>80), 0.7/day-(LAS 61–80), 0.6/day-(LAS 40–60), 0.4/day-(LAS<40); acceptable offers – 0.34/day-(LAS>80), 0.32/day-(LAS 61–80), 0.24/day-(LAS 40–60), 0.15/day-(LAS<40) (both P < 0.001 between all LAS). Among patients who experienced waitlist mortality/decompensation, ≥1 acceptable offer was declined in 92% (3939/4270) of patients – 78% for LAS >80, 88% for LAS 61–80, 93% for LAS 40–60, and 96% for LAS <40. Thirty-day waitlist mortality/decompensation rates were: 46%-(LAS>80), 24%-(LAS 61–80), 5%-(LAS 40–60), <1%-(LAS<40) (P < 0.001 between all). PTS was equivalent between patients for whom the first/second offer vs later offers were accepted (all LAS P > 0.4). The first offers that LTx candidates receive (including acceptable organs) are declined for nearly all candidates. Healthier candidates can afford offer selectivity but more ill patients (LAS>60) cannot, experiencing exceedingly high 30-day waitlist mortality.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Seminars in Thoracic and Cardiovascular Surgery
Seminars in Thoracic and Cardiovascular Surgery Medicine-Pulmonary and Respiratory Medicine
CiteScore
5.80
自引率
0.00%
发文量
324
审稿时长
12 days
期刊介绍: Seminars in Thoracic and Cardiovascular Surgery is devoted to providing a forum for cardiothoracic surgeons to disseminate and discuss important new information and to gain insight into unresolved areas of question in the specialty. Each issue presents readers with a selection of original peer-reviewed articles accompanied by editorial commentary from specialists in the field. In addition, readers are offered valuable invited articles: State of Views editorials and Current Readings highlighting the latest contributions on central or controversial issues. Another prized feature is expert roundtable discussions in which experts debate critical questions for cardiothoracic treatment and care. Seminars is an invitation-only publication that receives original submissions transferred ONLY from its sister publication, The Journal of Thoracic and Cardiovascular Surgery. As we continue to expand the reach of the Journal, we will explore the possibility of accepting unsolicited manuscripts in the future.
期刊最新文献
Aortic Dissection Following Transcatheter Aortic Valve Replacement. Systematic Review of the Comparative Studies of Image-guided Thermal Ablation, Stereotactic Radiosurgery, and Sublobar Resection for Treatment of High-Risk Patients with Stage I Non-Small Cell Lung Cancer. Systematic Review of Stereotactic Ablative Radiotherapy (SABR)/ Stereotactic Body Radiation Therapy (SBRT) for Treatment of High-Risk Patients with Stage I Non-Small Cell Lung Cancer. Systematic Review of Sublobar Resection for Treatment of High-Risk Patients with Stage I Non-Small Cell Lung Cancer. Aortic Valve Replacement for Moderate and Asymptomatic Severe Aortic Stenosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1